ST. LOUIS — Lying on top of an operating room table with his chest exposed, Larry Black Jr. was moments away from having his organs harvested when a doctor ran breathlessly into the room. “Get him off the table,” the doctor recalled telling the surgical team at SSM Health Saint Louis University Hospital as the…
Headspace recently introduced Ebb, an empathetic AI companion. It helps users reflect and sort through their emotions, and provides recommendations for mental health content. The post Headspace Introduces AI Companion To Support Patients Through ‘Ebbs and Flows’ of Life appeared first on MedCity News.
Hospitals’ flat revenues are clashing with rising costs and excessive reimbursement denials from payers, said Rod Hanners, CEO of Keck Medicine of USC. He warned that policy efforts focused solely on limiting provider payments ignore the larger issue of unchecked profits among payers, drugmakers and other healthcare industry players. The post Why Hospitals Are Losing…
The way venture capital firms invest in biotech startups has changed. Veteran VCs Chris Garabedian and Arjun Goyal offered their perspectives during a panel discussion at the World Medical Innovation Forum. The post Two Venture Investors Offer Their Takes on the State of Biotech Investing Today appeared first on MedCity News.
It seems no one is taking covid-19 seriously anymore, said Mollee Loveland, a nursing home aide who lives outside Pittsburgh. Loveland has seen patients and coworkers at the nursing home where she works die from the viral disease. Now she has a new worry: bringing home the coronavirus and unwittingly infecting her infant daughter, Maya,…
Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of programs covered under the agreement. The post Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagship’s Valo Health appeared first on MedCity News.
What sets vocal analysis apart is its simplicity and scale. Through a single 40‑second voice sample, multiple conditions can be screened simultaneously — no needles, no lab visits, and no physical presence required. The post The Future of Healthcare Screenings: The Power of Vocal Biomarkers appeared first on MedCity News.
Freenome’s SPAC merger agreement comes as the liquid biopsy developer prepares for potential 2026 commercialization of SimpleScreen, a colorectal cancer test currently under FDA review. If approved, the Freenome blood test would compete against Guardant Health’s liquid biopsy, Shield. The post Liquid Biopsy Firm Freenome Finds a Way to the Public Markets via $330M SPAC…
issue brief provides an overview of actions by the Trump administration and Congress that are likely to affect lawfully present immigrants’ access to health coverage and care, including new restrictions on eligibility for coverage and services as well as changes in immigration enforcement and other policies.
As RNA biology and RNA therapeutics emerge in the mainstream of pharma, RNA foundation models offer massive potential for revolutionizing R&D. The post RNA Foundation Models to Improve Pharma R&D Productivity appeared first on MedCity News.